This morning the Federal Circuit issued two precedential opinions, one in a patent case and one in a government contract case. Here are the introductions to the opinions.

Persion Pharmaceuticals LLC v. Alvogen Malta Operations Ltd. (Precedential)

Persion Pharmaceuticals LLC appeals from a decision of the U.S. District Court for the District of Delaware finding the asserted claims of U.S. Patent Nos. 9,265,760 and 9,339,499 invalid as obvious and lacking adequate written description. Because we find no reversible error in the district court’s obviousness determination, we affirm on that basis and do not reach the written description issue.

DAI Global, LLC v. Administrator of the United States Agency for International Development (Precedential)

DAI Global, LLC (DAI), formerly known as Development Alternatives, Inc., appeals a decision by the Civilian Board of Contract Appeals (Board) dismissing DAI’s five appeals for lack of jurisdiction. See Developmental Alts., Inc. v. Agency for Int’l Dev., CBCA No. 5942, CBCA 5943, CBCA 5944, CBCA 5945, CBCA 5946, 18-1 BCA ¶ 37147. Because the Board has jurisdiction to consider DAI’s appeals, we reverse and remand.